Implementation of local public expenses project for influenza vaccination and its influencing factors in China
ZENG Ge1, ZHENG Jian-dong2, LIU He3, LUO Kai-wei1, PENG Zhi-bin2, FENG Lu-zhao2, GAO Li-dong1
1. Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan 410005, China; 2. Chinese Center for Disease Control and Prevention, Beijing 102206, China; 3. Shenzhen Sanofi Pasteur Biological Products Co. , Ltd. , Beijing 100020, China
Abstract：Objective To investigate the general situation of regions implemented or with the intentto implement the public expenses project for influenza vaccination in China,to analyze the key points of implementation of the project, and to provide a basis for policy making. Methods Qualitative interviews and online surveys were conducted among the backbones of the public expenses project for influenza vaccination in disease control and prevention centers (CDCs) of regions with the project implemented in 2018 and to be implemented within the next three years. SPSS 20.0 software was used for statistical analysis. Results A total of 11 regional CDCs with the project implemented and 54 regional CDCs with the intent to implement the project were investigated. Senior citizens were the main target population in the regions with the project implemented, followed by primary and secondary school students and medical staff. Urban aging was one of the factors affecting the progress of the project, and the proportion of elderly population was significantly higher in the regions with full confirmation of the administrative department and the project to be implemented within the same year than in other regions (20.66% vs. 17.59%). In addition, coordinating with the administrative department and obtaining support (81.48%) were considered to be the main implementation bottleneck, followed by administration and allocation of influenza vaccine (44.44%), influenza vaccination campaign in the free-vaccination population (33.33%), making a disposal plan for adverse events following immunization (27.78%) and training and deployment of vaccinators in community health care service centers (18.52%). Conclusions The elderly are the main target group of the public expenses project for influenza vaccination, and urban aging is one of the factors affecting the progress of the project. CDCs are the key to the initiation of the project; and hence, as for the regions with the intent to implement the project, CDCs should take the initiative to advocate the project and use expertise to influence the decision-making of government departments.
曾舸, 郑建东, 刘禾, 罗垲炜, 彭质斌, 冯录召, 高立冬. 全国流感疫苗接种地方公费项目实施情况及影响因素调查[J]. 实用预防医学, 2020, 27(4): 446-450.
ZENG Ge, ZHENG Jian-dong, LIU He, LUO Kai-wei, PENG Zhi-bin, FENG Lu-zhao, GAO Li-dong. Implementation of local public expenses project for influenza vaccination and its influencing factors in China. , 2020, 27(4): 446-450.
[1] 徐喜卿,李顺平.我国甲型H1N1流感疫苗免疫效果评估系统综述[J].实用预防医学,2016,23(4):506-508. [2] World Health Organization. Global influenza strategy 2019-2030[R]. Geneva :WHO,2019:1-38. [3] 颜洁,杨土保.湖南省2011—2014年出生儿童流感病毒裂解疫苗接种情况分析[J]. 实用预防医学,2019,26(9):1119-1120. [4] 黄福新,吕星,程小雯,等. 深圳居民甲型 H1N1流感抗体水平影响因素的研究[J].实用预防医学,2014,21(8):932-933. [5] 冯录召,彭质斌,王大燕,等. 中国流感疫苗预防接种技术指南(2018—2019)[J]. 中华预防医学杂志,2018,52(11):1101-1114. [6] 彭质斌,王大燕,杨娟,等. 中国流感疫苗应用现状及促进预防接种的政策探讨[J]. 中华流行病学杂志,2018,39(8):1045-1050. [7] Yang J, Atkins KE, Feng L, et al. Seasonal influenza vaccination in China: landscape of diverse regional reimbursement policy, and budget impact analysis[J]. Vaccine,2016,34(47):5724-5735. [8] Zhang Y, Muscatello DJ, Wang Q, et al. Overview of influenza vaccination policy in Beijing, China: current status and future prospects[J]. J Public Health Policy,2017,38(3):366-379. [9] Lv M, Fang R, Wu J, et al. The free vaccination policy of influenza in Beijing, China: the vaccine coverage and its associated factors[J]. Vaccine,2016,34(18):2135-2140. [10] World Health Organization. Vaccines against influenza WHO position paper - November 2012[J]. Wkly Epidemiol Rec,2012,87(47):461-476. [11] 伊赫亚,冯录召,杨维中. 流感免疫策略专家研讨会会议纪要[J]. 中国病毒病杂志,2017,7(6):401-404. [12] 万家钰. 宁海县长街镇老年人流感疫苗接种率及认知影响因素调查[J]. 健康导报.医学版,2015,20(3):264. [13] 贾耀珠,程晓,孙利华. 广州60岁以上老年人免费接种流感疫苗的预算影响分析[J]. 中国药房,2017,28(35):4906-4909. [14] 王富华,谢铮,吕敏,等. 北京户籍老人免费流感疫苗接种情况及城乡差异分析[J]. 北京大学学报(医学版),2013,45(3):432-436. [15] Mauskopf J, Klesse M, Lee S, et al. The burden of influenza complications in different high-risk groups: a targeted literature review[J]. J Med Econ,2013,16(2):264-277. [16] Hardelid P, Pebody R, Andrews N. Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales, 1999-2010[J]. Influenza Other Respir Viruses,2013,7(1):35-45. [17] Reed C, Chaves SS, Daily KP, et al. Estimating influenza disease burden from population-based surveillance data in the United States[J]. PLoS One,2015,10(3):e118369. [18] Li L, Liu Y, Wu P, et al. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study[J]. Lancet Public Health 2019, 4:e473-481. [19] Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly[J]. N Engl J Med,2007,357(14):1373-1381. [20] Beyer WE, Mcelhaney J, Smith DJ, et al. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza[J]. Vaccine,2013,31(50):6030-6033. [21] Black CL, Yue X, Ball SW, et al. Influenza vaccination coverage among health care personnel - United States, 2015-16 influenza season[J]. MMWR Morb Mortal Wkly Rep,2016,65(38):1026-1031.
2020, Vol. 27 
